Home  »  Company  »  GlaxoSmithKline Pharmaceuticals Ltd.  »  Quotes  »  Audited Results
Enter the first few characters of Company and click 'Go'

Audited Results of GlaxoSmithKline Pharmaceuticals Ltd. Company

(Rs in Cr.) Mar 31, 2016 Mar 31, 2015 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Operating Income 2,756.96 3,287.58 2,546.15 2,630.30 2,345.88
Manufacturing Expenses 25.97 31.17 23.85 13.75 90.86
Personnel Expenses 443.37 493.02 362.05 295.52 278.79
Selling Expenses 0.00 0.00 0.00 0.00 157.43
Administrative Expenses 572.55 624.38 476.19 400.50 118.48
Expenses Capitalised 0.00 0.00 0.00 0.00 0.00
Cost Of Sales 2,279.61 2,660.39 2,024.07 1,811.17 1,557.22
Operating Profit 477.35 627.19 522.08 819.14 788.66
Other Recurring Income 121.83 198.67 200.97 193.48 170.15
Adjusted PBDIT 599.18 825.86 723.05 1,012.62 958.80
Financial Expenses 0.00 0.00 0.00 0.00 0.33
Depreciation 24.78 25.35 19.88 17.84 20.41
Other Write offs 0.00 0.00 0.00 0.00 0.00
Adjusted PBT 574.40 800.50 703.17 994.78 938.07
Tax Charges 201.80 276.98 227.44 269.30 297.39
Adjusted PAT 372.60 523.53 475.73 725.48 640.68
Non Recurring Items 2.61 -51.88 26.15 -148.22 -231.84
Other Non Cash adjustments 0.00 0.00 0.00 0.00 21.76
Reported Net Profit 375.21 471.65 501.88 577.26 430.60
Equity Dividend 337.30 421.62 352.32 359.85 320.85
Preference Dividend 0.00 0.00 0.00 0.00 0.00
Retained Earnings 838.94 1,042.18 1,221.31 1,264.34 1,213.97
 
Subscribe now to get personal finance updates in your inbox!